Introduction
Transforming growth factor-1 (TGF-1) is a multifunctional cytokine that is essential for maintaining homeostasis involving bone and muscle differentiation, immune response, and tumor suppression (Massagué 1998; Alliston et al. 2001; Centrella et al. 1994; Brennan et al. 1991; Liu et al. 2001; Werner et al. 2000; Derynck et al. 2001) . The role of TGF-1 in bone formation was confirmed by our previous work that showed that mutations in the latency-associated polypeptide domain of its gene (TGFB1) cause CamuratiEngelmann disease, a heritable bone-sclerosing disorder (Kinoshita et al. 2000; Saito et al. 2001) . In addition, an inverse-looking condition, osteoporosis, may be associated with TGFB1. Yamada et al. (1999) demonstrated in Japanese osteoporotic patients such an association in an exonic single-nucleotide polymorphism (SNP), namely, a CAET substitution at nucleotide (nt) position 29 in TGFB1. A similar association was obtained in an Italian population, although a polymorphism (713-8delC) in the gene showing the association was different (Bertoldo et al. 2000) .
At least six molecules other than TGF-1 have been known to participate in the TGF-1 signaling pathway. They include TGF-type I receptor (T R-I), TGF-type II receptor (T R-II), SMAD2, SMAD3, SMAD4, and SMAD7. Thus, identification of nucleotide polymorphisms in genes TGFB1, TGFBR1, TGFBR2, SMAD2, SMAD3, SMAD4, and SMAD7 for these seven proteins may be useful to clarify osteoporotic disorders.
In this article, we provide a series of fine-scale maps of variations in these genes. These maps contain a total of 106 SNPs and 11 other types of variants in a Japanese population.
genetic polymorphisms. The genes are those for molecules composing the TGF -1 signaling pathway. Blood samples were obtained with informed consent from 48 healthy Japanese individuals in Nagasaki prefecture. On the basis of genomic sequences from GenBank database, we designed primers to amplify all exons of these genes as well as sequences at 1.5-kb 5Ј-and 3Ј-flanking regions and 5Ј-and 3Ј-untranslated regions (UTRs). Genomic DNA was prepared from lymphocytes by standard phenol/ chloroform extraction and isopropanol precipitation, and 10 ng of it was used as a template for polymerase chain reaction (PCR).
PCR was performed first using DNA from 16 normal individuals in a 10-µl reaction volume, containing 500 nM of each primer, 0.2 units of Takara ExTaq HS-version (Takara, Otsu, Japan), ExTaq buffer, and a 200-µM deoxyribonucleosido triphosphate mixture. PCR products were purified using a PCR purification kit (Qiagen, Hilden, Germany) or ExoSAP-IT (USB, Cleveland, OH, USA) according to the manufacturers' protocols. The purified PCR products were sequenced using the Big-Dye terminator kit version 3.0 (PE Applied Biosystems, Foster City, CA, USA) and run on an Autosequencer (ABI PRISM 3100, PE Applied Biosystems). The electropherogram was aligned by Autoassembler software (PE Applied Biosystems), and SNPs were detected on the aligned electropherogram.
Sequence analysis was extended to a total of 48 persons (96 chromosomes), and allele frequency was then calculated.
Results
We identified a total of 106 SNPs and 11 other types of variations in the seven genes among 48 healthy Japanese individuals. Fine physical maps of these genes are shown in Fig. 1 , and detailed information on the genetic variations is summarized in Tables 1 and 2 . Of the 106 SNPs identified, 79 (75%) had not been deposited in the SNP database (dbSNP) of the U.S. National Center for Biotechnology Information, and 9 (TGFB1-6, TGFB1-7, TGFB1-8, TGFB1-10, TGFBR1-6, SMAD3-4, SMAD3-16, SMAD3-17, and SMAD3-18) were observed within regions that correspond to repetitive sequences predicted by the RepeatMasker Program (http://ftp.genome.washington. edu/cgi-bin/RepeatMasker). Five SNPs (TGFBR2-4, SMAD4-7, SMAD7-8, SMAD7-9, SMAD7-14) and one insertion (SMAD7-19) were rare polymorphisms that were not identified in 16 persons at first, but they were unexpectedly identified near the common SNPs during the sequencing for 48 persons. Of five SNPs identified within coding regions of the genes, two were nonsynonymous and predicted to result in amino-acid substitutions that might affect the structure and biological function of the respective gene products. Detailed information of the 106 SNPs and 11 other variants in the seven genes is provided in the following paragraphs.
SNPs in TGFB1
A total of 11 SNPs were identified in TGFB1. They included one at the 5Ј-flanking region, one in the coding region and nine in introns. The only SNP (TGFB1-2, 29CAET) found in the coding region (exon 1) was nonsynonymous and predicted to change from proline to leucine (P10L). This change has already been observed in another Japanese population (Yamada et al. 2001) . Frequencies of C and T alleles at the TGFB1-2 locus among the 48 individuals were estimated to be 58.3% and 41.7%, respectively. A deletion polymorphism (one-base deletion in intron 4, 713-8delC), frequently observed in an Italian population (Bertoldo et al. 2000) , was not found in our study.
Polymorphisms in TGFBR1 and TGFBR2
Thirteen SNPs were identified in TGFBR1, including 12 in introns, and 1 in the 3Ј-UTR. In TGFBR2, 31 SNPs were identified: 1 in exon 4, 27 in introns, and 3 in the 3Ј-UTR. The SNP (TGFBR2-18, 571GAEA) in exon 4 was nonsynonymous (V191I), although the A allele was very rare with a frequency of 1.0%. Two deletion polymorphisms were also identified in the TGFBR2 genomic region.
Polymorphisms in the SMAD gene family
All six SNPs identified in SMAD2 were located in its introns. In SMAD3, a total of 21 SNPs were identified. They included 1 (SMAD3-5) in exon 2, 1 each in the 5Ј-flanking and in the 3Ј-UTRs, and 18 SNPs in introns. The SMAD3-5 was synonymous (A309G, L103L). Other variations observed in SMAD3 were one deletion (SMAD3-22), 2 insertions (SMAD3-23, and SMAD3-24), and one tandem repeat polymorphism (SMAD3-25). In SMAD4, there were two SNPs in the 5Ј-flanking region, four in introns, and two in the 3Ј-UTR. In addition, one deletion polymorphism (SMAD4-9) was identified in its intron 3. In SMAD7, a total of 16 SNPs were identified, 2 (SMAD7-11, and SMAD7-12) in the coding region, 10 in introns, one in the 3Ј-UTR, and 3 in the 3Ј-flanking region. Both SMAD7-11 and SMAD7-12 were synonymous (L298L and G402G, respectively). Two deletions (SMAD7-17 and SMAD7-18) and two insertions (SMAD7-19 and SMAD7-20) were also identified.
Discussion
We have identified a total of 106 SNPs and 11 deletion/ insertion/tandem-repeat polymorphisms in the seven genes that participate in the TGF-1 signaling pathway. Because the pathway concerns bone and muscle differentiation, immunosuppression, and carcinogenesis, the variants we identified are useful for such research fields. It has repeatedly been reported that alterations of the pathway affect various human disorders. A lack of growth inhibition by TGF-leads to carcinogenesis (Massagué 1998) , and excess TGF-activity may play a significant role in the pathogen- Fig. 1 . Genomic organizations of seven genes composing the TGF-1 signaling pathway, and locations of Single-nucleotide polymorphisms (SNPs) in the genes: the TGF-1 gene (TGFB1), the transforming growth factor-type I receptor gene (TGFBR1), the transforming growth factor-type II receptor gene (TGFBR2), the SMAD2 gene (SMAD2), the SMAD3 gene (SMAD3), the SMAD4 gene (SMAD4), and the SMAD7 gene (SMAD7). Exons (their numbers are below lines) are depicted by open boxes, and SNPs and other variants (in parentheses) are indicated above lines. Detailed information for the polymorphisms in each gene is shown in Tables 1 and 2 . Total length of TGFBR2, SMAD2, and SMAD3 was unknown because of gaps in DNA sequences esis of fibrotic disorders in the kidney (Border et al. 1992) and in inflammatory disorders (Shull et al. 1992; Kulkarni et al. 1993) . As mentioned earlier, germline mutations in TGFB1 cause a heritable bone sclerosing disorder, Camurati-Engelmann disease (Kinoshita et al. 2000; Saito et al. 2001) . Moreover, certain polymorphisms in TGFB1 have recently been reported to be associated with the degree of bone mineral density and susceptibility to osteoporosis (Bertoldo et al. 2000; Yamada et al. 2001) , as well as with asthma severity (Pulleyn et al. 2001) . Somatic Table 1 . SNPs and other polymorphisms in TGFB1, TGFBR1, and TGFBR2 in a Japanese population SNPs, Single-nucleotide polymorphisms; nt, nucleotide; dbSNP, database of SNPs; NCBI, National Center for Biotechnology Information; FR, flanking region; UTR, untranslated region; DEL, deletion; DEL*, del(AATTT) a Nucleotide numbering is according to the mutation nomenclature (den Dunnen and Antonarakis 2000) mutations in TGFBR2 were found in gastrointestinal cancers with microsatellite instability (Myeroff et al. 1995) . Inactivated SMAD2 and SMAD4 caused by nucleotide alterations, and regional or entire chromosomal deletions involving the genes, were observed to be associated with pancreatic cancer . Originally, SMAD4 was identified as a candidate tumor suppressor gene, and a large number of all human pancreatic cancers are caused by somatic deletions or mutations of SMAD4, also referred to as DPC4 (the deleted in pancreatic carcinoma locus 4) . In addition, abnormalities of TGF-1 and other molecules composing the signaling pathway are involved in many other disorders (Myeroff et al. 1995; Knaus et al. 1996; Eppert et al. 1996; Schutte et al. 1996) .
In conclusion, our collection of genetic variations for the seven genes provides useful genetic data for research, not only on the TGF-1 signaling pathway, but also on its related disorders. Identification of genes that concern such disorders will contribute to future personalized medical service.
